Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics to Present at the New York Biotechnology Association 18th Annual Meeting
May 8th, 2009
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Anthony Caggiano, M.D., Ph.D., Vice President, Preclinical Development, will present at the upcoming New York Biotechnology Association (NYBA) Annual Meeting on Monday, April 20, 2009 at 9:20 a.m. Eastern Time at the Marriott Marquis Hotel in New York, NY. Dr. Caggiano will present an overview of Acorda’s clinical and preclinical pipeline as part of the NYBA Bioscience Industry Showcase. For information and registration for the Showcase, please contact Patricia Wadington at New York Biotechnology Association, pwadington@nyba.org, 631-444-8895. Investor and strategic partner registration for the Showcase is...
Source: Health Business Week (2009-05-08)
|
